Hohimer Wealth Management, LLC Gain Therapeutics, Inc. Transaction History
Hohimer Wealth Management, LLC
- $424 Million
- Q2 2024
A detailed history of Hohimer Wealth Management, LLC transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Hohimer Wealth Management, LLC holds 330,000 shares of GANX stock, worth $719,400. This represents 0.1% of its overall portfolio holdings.
Number of Shares
330,000Holding current value
$719,400% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding GANX
# of Institutions
31Shares Held
3.75MCall Options Held
0Put Options Held
0-
Timelo Investment Management Inc.605KShares$1.32 Million0.45% of portfolio
-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$1.28 Million0.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$1.23 Million0.04% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL450KShares$981,0000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA184KShares$400,5440.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $25.9M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...